Meanwhile, ACSL4 appears to be abnormally expressed in a variety of clinical cancers, and ACSL4 overexpression in hepatocellular carcinoma is often predictive of poor prognosis related to HCC patients (Feng et al. 2021). The gene discussed is ACSL4; the disease is cancer.